Edicotinib (Synonyms: JNJ-40346527; JNJ-527) |
Katalog-Nr.GC19418 |
Edicotinib (JNJ-40346527) ist ein potenter, selektiver, in das Gehirn eindringender und oral aktiver Hemmer des Kolonie-stimulierenden Faktor-1-Rezeptors (CSF-1R) mit einem IC50 von 3,2 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1142363-52-7
Sample solution is provided at 25 µL, 10mM.
Edicotinib is a selective and orally available colony-stimulating factor-1 (CSF-1) receptor inhibitor, and has entered phase IIA clinical trial to study rheumatoid arthritis (RA) despite disease.
[1]. Genovese MC, et al. Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy. J Rheumatol. 2015 Oct;42(10):1752-60.
Average Rating: 5
(Based on Reviews and 1 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *